Everolimus
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72319-016 -
Package NDC
72319-016-02 -
Package NDC
72319-016-60 -
Application number
ANDA219464 -
SPL ID
5afb5d8b-631c-48bd-e063-6294a90acfe3 -
SPL set ID
be5da0fd-8fd4-4f84-a307-f270048d503c -
UNII
9HW64Q8G6G -
RxCUI
977427 -
RxCUI
977434 -
RxCUI
977438 -
RxCUI
2056895
What the source publishes
- Labeler
- i3 Pharmaceuticals, LLC
- Active ingredients
- everolimus
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Everolimus",
"splId": "5afb5d8b-631c-48bd-e063-6294a90acfe3",
"labels": [
{
"setId": "be5da0fd-8fd4-4f84-a307-f270048d503c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be5da0fd-8fd4-4f84-a307-f270048d503c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be5da0fd-8fd4-4f84-a307-f270048d503c"
}
],
"routes": [
"ORAL"
],
"labeler": "i3 Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET in 1 CONTAINER (72319-016-02)",
"package_ndc": "72319-016-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
},
{
"sample": false,
"description": "60 BLISTER PACK in 1 CARTON (72319-016-60) / 10 TABLET in 1 BLISTER PACK (72319-016-10)",
"package_ndc": "72319-016-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
}
],
"productId": "72319-016_5afb5d8b-631c-48bd-e063-6294a90acfe3",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "72319-016",
"deaSchedule": null,
"genericName": "everolimus",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EVEROLIMUS",
"strength": ".75 mg/1"
}
],
"applicationNumber": "ANDA219464",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260807",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175605",
"N0000175076",
"N0000182141",
"N0000182137",
"N0000175625",
"N0000175624",
"N0000175550"
],
"upc": [
"0372319015021",
"0372319016103",
"0372319017025",
"0372319003608",
"0372319015106",
"0372319003028",
"0372319003103",
"0372319017605",
"0372319015601",
"0372319016608",
"0372319017100",
"0372319016028"
],
"unii": [
"9HW64Q8G6G"
],
"rxcui": [
"977427",
"977434",
"977438",
"2056895"
],
"spl_set_id": [
"be5da0fd-8fd4-4f84-a307-f270048d503c"
],
"pharm_class_pe": [
"Decreased Immunologic Activity [PE]"
],
"pharm_class_epc": [
"Kinase Inhibitor [EPC]",
"mTOR Inhibitor Immunosuppressant [EPC]"
],
"pharm_class_moa": [
"Protein Kinase Inhibitors [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"mTOR Inhibitors [MoA]"
],
"manufacturer_name": [
"i3 Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72319-016_5afb5d8b-631c-48bd-e063-6294a90acfe3"